Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.
CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.
CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.
Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.
CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.
The Anti-Cardiolipin Antibody Test detects antibodies against cardiolipin, aiding in the diagnosis of antiphospholipid syndrome (APS) and evaluating the risk of blood clots.
A blood sample is collected from your arm and analyzed for the presence of anti-cardiolipin antibodies.
No special preparation or fasting is required. You can eat and drink normally before the test.
Results are typically available within 1-2 days, depending on the laboratory’s processing time.
Discuss any abnormal results with your healthcare provider for guidance on further tests or treatment options based on your specific condition.
Dengue fever is a mosquito-borne viral infection causing flu-like symptoms, and in severe cases, it can lead to dengue hemorrhagic fever or dengue shock syndrome.
Anyone experiencing symptoms of dengue fever, particularly within the first few days of illness, should consider this test for early diagnosis.
Yes, the Dengue NS1 Antigen Test is highly accurate in detecting early dengue infection, especially within the first five days of symptom onset.
The test involves a blood draw, which is then analyzed in a laboratory to detect the NS1 antigen.
A positive result indicates a dengue infection. Your healthcare provider will discuss treatment options and may recommend further testing or monitoring.